BioCentury
ARTICLE | Company News

AnGes, BioLeaders to develop oral hypertension vaccine

April 13, 2012 12:07 AM UTC

AnGes MG Inc. (Tokyo:4563) and BioLeaders Corp. Co. Ltd. (Daejeon, South Korea) partnered to develop an oral DNA vaccine to treat hypertension. The vaccine will target the angiotensin II type 1 (AT1) ...